Radiobiology for Children's Health Program, Research Center for Radiation Protection, National Institute of Radiological Sciences, Chiba, Japan.
Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):1134-40. doi: 10.1016/j.ijrobp.2012.08.035. Epub 2012 Oct 19.
The risk of developing secondary cancer after radiotherapy, especially after treatment of childhood cancers, remains a matter of concern. The high biological effects of carbon-ion radiation have enabled powerful radiotherapy, yet the approach is commonly restricted to the treatment of adults. Susceptibility of the fetus to particle radiation-induced cancer is also unclear. The present study is aimed to investigate the effect of carbon-ion irradiation in childhood on breast carcinogenesis.
We irradiated female Sprague-Dawley rats of various ages (embryonic days 3, 13, and 17 and 1, 3, 7, and 15 weeks after birth) with (137)Cs γ rays or a 290-MeV/u monoenergetic carbonion beam (linear energy transfer, 13 keV/μm). All animals were screened weekly for mammary carcinoma by palpation until they were 90 weeks old.
Irradiation of fetal and mature (15-week-old) rats with either radiation source at a dose of 0.2 or 1 Gy did not substantially increase the hazard ratio compared with the nonirradiated group. Dose responses (0.2-2.0 Gy) to γ rays were similar among the groups of rats irradiated 1, 3, and 7 weeks after birth. The effect of carbon ions increased along with the age at the time of irradiation, indicating relative biological effectiveness values of 0.2 (-0.3, 0.7), 1.3 (1.0, 1.6), and 2.8 (1.8, 3.9) (mean and 95% confidence interval) for animals that were 1, 3, and 7 weeks of age, respectively.
Our findings imply that carbonion therapy may be associated with a risk of secondary breast cancer in humans, the extent of which may depend on the age of the patient at the time of irradiation.
放疗后,尤其是儿童癌症治疗后,继发性癌症的风险仍然令人担忧。碳离子辐射的高生物效应使其成为一种强大的放疗手段,但该方法通常仅限于成人治疗。胎儿对粒子辐射诱导癌症的敏感性也不清楚。本研究旨在探讨碳离子照射对儿童期乳腺癌发生的影响。
我们用(137)Cs γ射线或 290 MeV/u 的单能碳离子束(线性能量转移,13 keV/μm)照射不同年龄的雌性 Sprague-Dawley 大鼠(胚胎第 3、13 和 17 天以及出生后 1、3、7 和 15 周)。所有动物每周通过触诊筛查乳腺癌,直到 90 周龄。
用两种辐射源照射胎儿和成熟(15 周龄)大鼠,剂量为 0.2 或 1 Gy,与未照射组相比,危害比没有显著增加。出生后 1、3 和 7 周接受照射的大鼠组的 γ 射线剂量反应(0.2-2.0 Gy)相似。碳离子的作用随着照射时的年龄而增加,表明相对生物有效性值分别为 0.2(-0.3,0.7)、1.3(1.0,1.6)和 2.8(1.8,3.9)(平均值和 95%置信区间),对于分别为 1、3 和 7 周龄的动物。
我们的发现表明,碳离子治疗可能与继发性乳腺癌的风险相关,其程度可能取决于患者在照射时的年龄。